CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Germany [Published by Global Data] Prices from USD $1995

02:58 EDT 16 Aug 2019 | BioPortfolio Reports

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Germany


GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Germany". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Germany. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Germany. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and inhouse analysis by GlobalData's team of industry experts.

Germany is a mature healthcare market, with a strong focus on pharma RD, production, and government policies supporting higher healthcare expenditure. In 2017, Germany spent $5,728 per capita on healthcare, which was higher than the OECD average of $4,069 per capita. In 2010, Germany had pharmaceutical sales of $39.4B. This increased to $40B in 2016. The market value is expected to reach $40.5B in 2022, growing at a Compounded Annual Growth Rate CAGR of 0.25%. The German medical device market was valued at $28B in 2015, which increased to $33.7B in 2020, growing at a CAGR of 3.7%.The increasing elderly population and associated disease burden are expected to drive the growth of the pharmaceutical market. However, the government initiated pricecap agreements to reduce healthcare expenditure have limited growth. The German healthcare system is characterized by universal insurance coverage, good accessibility to healthcare facilities, and adequate healthcare reimbursement. Germany offers more than 30 specialized cluster networks focusing on continuous innovation and RD.


The report provides information on the healthcare, regulatory, and reimbursement landscape in Germany, and includes

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market Merck, Bayer, Pfizer, Boehringer Ingelheim and Novartis and profiles and SWOT analyses of the major players in the medical device market Medtronic, Fresenius, GE Healthcare, Essilor and B Braun

Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Germany

Porter's five forces analysis for pharmaceutical and medical devices market of Germany

An insightful review of the reimbursement and regulatory landscape, of which analysis include details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices

Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in Germany healthcare market.

Reasons to buy

This report will enhance your decisionmaking capability by allowing you to

Develop business strategies by understanding the trends shaping and driving the Germany healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Identify, understand, and capitalize on the opportunities and challenges in Germany healthcare market.

Original Article: CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Germany [Published by Global Data] Prices from USD $1995


More From BioPortfolio on "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Germany [Published by Global Data] Prices from USD $1995"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...